First Trust NYSE Arca Biotechnology Index Fund
255 hedge funds and large institutions have $746M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 98 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
255
Holders Change
+15
Holders Change %
+6.25%
% of All Funds
3.74%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
53
Reduced
98
Closed
22
Calls
$948K
Puts
–
Net Calls
+$948K
Net Calls Change
-$457K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$120M |
| 2 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
+$7.47M |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$4.47M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$2.11M |
| 5 |
Jane Street
New York
|
+$1.9M |
Top Sellers
| 1 |
SOS
Silver Oak Securities
Jackson,
Tennessee
|
-$67.6M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$9.42M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$8.07M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.18M |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$5.26M |